Cotreau Violetta 4
4 · Akebia Therapeutics, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Cotreau Violetta
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2022-01-03$2.29/sh−5,833$13,335→ 33,067 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on December 31, 2020.